Healthcare Swiss Investing Ideas

CHF 58
17.2% undervalued intrinsic discount
Revenue
1.69% p.a.
Profit Margin
7.73%
Future PE
20.56x
Price in 2029
CHF 67.1
CHF 5.6
4.8% undervalued intrinsic discount
Revenue
2% p.a.
Profit Margin
5.48%
Future PE
9.96x
Price in 2029
CHF 6.27
CHF 227.3
21.3% undervalued intrinsic discount
Revenue
5.24% p.a.
Profit Margin
16.12%
Future PE
21.41x
Price in 2029
CHF 259.69